GYRE icon

Gyre Therapeutics

70 hedge funds and large institutions have $85.6M invested in Gyre Therapeutics in 2018 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 31 increasing their positions, 13 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding in top 10

Funds holding in top 10:

less ownership

Funds ownership:

less funds holding

Funds holding:

10% less capital invested

Capital invested by funds: $95.2M → $85.6M (-$9.58M)

24% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 17

80% less call options, than puts

Call options by funds: $679K | Put options by funds: $3.41M

Holders
70
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$679K
Puts
$3.41M
Net Calls
Net Calls Change

Top Buyers

1 +$2.76M
2 +$2.62M
3 +$2.55M
4
GCP
GSA Capital Partners
United Kingdom
+$1.75M
5
Two Sigma Investments
Two Sigma Investments
New York
+$1.56M

Top Sellers

1 -$9.69M
2 -$7.01M
3 -$1.67M
4
Renaissance Technologies
Renaissance Technologies
New York
-$1.57M
5
PE
Point72 Europe
United Kingdom
-$974K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$9.62M
2
$8.7M
3
$5.95M
4
$5.94M
5
$5.91M
6
$4.75M
7
$4.36M
8
$3.75M
9
$3.45M
10
$2.76M
11
$2.65M
12
$2.55M
13
$2.16M
14
$2.11M
15
$2.09M
16
$1.79M
17
$1.5M
18
$1.46M
19
$1.32M
20
$1.29M
21
$1.01M
22
$861K
23
$794K
24
$714K
25
$648K